One of India’s pharmaceutical companies with a strong global footprint, Lupin, has launched risperidone long-acting injectable with 180-day CGT exclusivity
Will heavy investments, capital-intensive innovations, and infrastructure development in the healthcare sector become unaffordable for the average person? This concern